These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23644659)

  • 1. Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro.
    Ki MK; Jeoung MH; Choi JR; Rho SS; Kwon YG; Shim H; Chung J; Hong HJ; Song BD; Lee S
    Oncogene; 2013 Nov; 32(48):5449-57. PubMed ID: 23644659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of VEGF-dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a.
    Kim TK; Park CS; Jang J; Kim MR; Na HJ; Lee K; Kim HJ; Heo K; Yoo BC; Kim YM; Lee JW; Kim SJ; Kim ES; Kim DY; Cha K; Lee TG; Lee S
    Mol Oncol; 2018 Mar; 12(3):356-372. PubMed ID: 29316206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CLEC14a-HSP70-1A interaction regulates HSP70-1A-induced angiogenesis.
    Jang J; Kim MR; Kim TK; Lee WR; Kim JH; Heo K; Lee S
    Sci Rep; 2017 Sep; 7(1):10666. PubMed ID: 28878328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.
    Mura M; Swain RK; Zhuang X; Vorschmitt H; Reynolds G; Durant S; Beesley JF; Herbert JM; Sheldon H; Andre M; Sanderson S; Glen K; Luu NT; McGettrick HM; Antczak P; Falciani F; Nash GB; Nagy ZS; Bicknell R
    Oncogene; 2012 Jan; 31(3):293-305. PubMed ID: 21706054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth.
    Noy PJ; Lodhia P; Khan K; Zhuang X; Ward DG; Verissimo AR; Bacon A; Bicknell R
    Oncogene; 2015 Nov; 34(47):5821-31. PubMed ID: 25745997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2).
    Noy PJ; Swain RK; Khan K; Lodhia P; Bicknell R
    FASEB J; 2016 Jun; 30(6):2311-23. PubMed ID: 26939791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
    Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R
    Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis.
    Lee S; Rho SS; Park H; Park JA; Kim J; Lee IK; Koh GY; Mochizuki N; Kim YM; Kwon YG
    J Clin Invest; 2017 Feb; 127(2):457-471. PubMed ID: 27991863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation.
    Kim Y; Lee S; Zhang H; Lee S; Kim H; Kim Y; Won MH; Kim YM; Kwon YG
    J Neuroinflammation; 2020 Feb; 17(1):48. PubMed ID: 32019570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth.
    Zhuang X; Maione F; Robinson J; Bentley M; Kaul B; Whitworth K; Jumbu N; Jinks E; Bystrom J; Gabriele P; Garibaldi E; Delmastro E; Nagy Z; Gilham D; Giraudo E; Bicknell R; Lee SP
    JCI Insight; 2020 Oct; 5(19):. PubMed ID: 33004686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours.
    Robinson J; Whitworth K; Jinks E; Nagy Z; Bicknell R; Lee SP
    J Pathol Clin Res; 2020 Oct; 6(4):308-319. PubMed ID: 32696621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics-based screening of the endothelial heparan sulfate interactome reveals that C-type lectin 14a (CLEC14A) is a heparin-binding protein.
    Sandoval DR; Gomez Toledo A; Painter CD; Tota EM; Sheikh MO; West AMV; Frank MM; Wells L; Xu D; Bicknell R; Corbett KD; Esko JD
    J Biol Chem; 2020 Feb; 295(9):2804-2821. PubMed ID: 31964714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clec14a is specifically expressed in endothelial cells and mediates cell to cell adhesion.
    Rho SS; Choi HJ; Min JK; Lee HW; Park H; Park H; Kim YM; Kwon YG
    Biochem Biophys Res Commun; 2011 Jan; 404(1):103-8. PubMed ID: 21095181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers.
    Zanivan S; Maione F; Hein MY; Hernández-Fernaud JR; Ostasiewicz P; Giraudo E; Mann M
    Mol Cell Proteomics; 2013 Dec; 12(12):3599-611. PubMed ID: 23979707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation.
    Khan KA; McMurray JL; Mohammed F; Bicknell R
    FEBS J; 2019 Sep; 286(17):3299-3332. PubMed ID: 31287944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance.
    Krishna Priya S; Kumar K; Hiran KR; Bindhu MR; Nagare RP; Vijaykumar DK; Ganesan TS
    Int J Clin Oncol; 2017 Feb; 22(1):107-117. PubMed ID: 27567920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLEC14A protects against podocyte injury in mice with adriamycin nephropathy.
    Su Z; Li Y; Lv H; Cui X; Liu M; Wang Z; Zhang Y; Zhen J; Tang W; Wang X; Yi F
    FASEB J; 2021 Jul; 35(7):e21711. PubMed ID: 34107098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLEC14A was up-regulated in hepatocellular carcinoma and may function as a potential diagnostic biomarker.
    Yan L; Li X; Yuan Y
    Clinics (Sao Paulo); 2022; 77():100029. PubMed ID: 35576868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group XIV C-type lectins: emerging targets in tumor angiogenesis.
    Yee EJ; Vigil I; Sun Y; Torphy RJ; Schulick RD; Zhu Y
    Angiogenesis; 2024 May; 27(2):173-192. PubMed ID: 38468017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of structural properties of the C-type-lectin-like domain (CTLD).
    Zelensky AN; Gready JE
    Proteins; 2003 Aug; 52(3):466-77. PubMed ID: 12866057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.